MeVis Medical Solutions (M3V) AI Stock Analysis

• Market Cap: €41.86M
• Dividend Yield: 3.86%
• Average Volume (3M): 99.00
• Price to Earnings (P/E): 14.3
• Beta (1Y): 0.19
• Revenue Growth: -5.72%
• EPS Growth: -25.19%
• Country: DE
• Employees: 100
• Sector: General
• Sector Strength: N/A
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 0.42
• Shares Outstanding: 1,820,000
• 10 Day Avg. Volume: 191
• 30 Day Avg. Volume: 99
• PEG Ratio: -0.46
• Price to Book (P/B): 2.53
• Price to Sales (P/S): 2.81
• P/FCF Ratio: 12.07
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 72 Outperform
• Price Target: €27.00 ▲(9.76% Upside)
• Action: Reiterated Date: 02/02/26
• Date: Action: Reiterated 02/02/26

The score is driven primarily by strong financial quality (notably a debt-free balance sheet and historically high margins) and supportive valuation (low P/E and solid dividend yield). These positives are partially offset by weakening revenue/profit trends and bearish technicals (price below key moving averages despite oversold RSI).

Positive Factors

Debt-free balance sheet

A zero-debt, equity-stable balance sheet materially lowers financial risk and preserves strategic optionality. Over months this supports consistent R&D and product engineering investment, resilience through contract seasonality, and the ability to fund opportunistic M&A or partnerships without refinancing strain.

Negative Factors

Three-year revenue decline

A persistent multi-year top-line contraction signals structural challenges in demand, customer retention, or competitive positioning. Continued revenue declines can erode operating leverage, limit reinvestment capacity for product roadmap execution, and ultimately pressure long-term revenue growth prospects and market share.

MeVis Medical Solutions Business Overview & Revenue Model

Company Description

MeVis Medical Solutions AG develops, markets, and sells software for analyzing and evaluating image data to equipment manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. ...

Read more

MeVis Medical Solutions AG develops, markets, and sells software for analyzing and evaluating image data to equipment manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. ...

How the Company Makes Money

MeVis Medical Solutions generates revenue through the sale and licensing of its proprietary software solutions to healthcare providers, hospitals, and medical research facilities. The company also offers maintenance and support services, which pro...

Read more

MeVis Medical Solutions generates revenue through the sale and licensing of its proprietary software solutions to healthcare providers, hospitals, and medical research facilities. The company also offers maintenance and support services, which pro...

MeVis Medical Solutions Financial Statement Overview

Breakdown	TTM	Sep 2025	Sep 2024	Sep 2023	Sep 2022	Sep 2021
Income Statement
Total Revenue	16.64M	16.06M	16.97M	17.34M	18.76M	16.21M
Gross Profit	5.93M	15.69M	16.48M	7.00M	18.02M	15.78M
EBITDA	3.49M	3.43M	4.82M	5.17M	7.97M	4.77M
Net Income	4.30M	3.17M	4.56M	4.92M	7.79M	4.55M
Balance Sheet
Total Assets	23.60M	25.89M	26.48M	28.05M	31.20M	27.53M
Cash, Cash Equivalents and Short-Term Investments	2.57M	6.52M	6.53M	7.74M	9.32M	7.62M
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	5.60M	8.06M	8.66M	10.23M	13.38M	9.71M
Stockholders Equity	18.01M	17.83M	17.83M	17.83M	17.83M	17.83M
Cash Flow
Free Cash Flow	0.00	3.74M	2.84M	5.77M	4.72M	9.08M
Operating Cash Flow	0.00	3.88M	3.15M	5.85M	4.86M	9.13M
Investing Cash Flow	0.00	945.46K	906.80K	989.98K	58.66K	111.63K
Financing Cash Flow	0.00	-4.56M	-4.92M	-7.79M	-4.55M	-5.70M

MeVis Medical Solutions Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 24.60
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:M3V, the sentiment is Negative. The current price of 24.6 is above the 20-day moving average (MA) of 23.80, above the 50-day MA of 23.90, and above the 200-day MA of 24.01, indicating a bearish trend. The MACD of -0.52 indicates Positive momentum. The RSI at 37.05 is Neutral, neither overbought nor oversold. The STOCH value of 24.31 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DE:M3V.

MeVis Medical Solutions Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
M3V	72 Outperform	€41.86M	14.26	13.44%	3.86%	-5.72%	-25.19%
DRW8	72 Outperform	€1.59B	9.32	9.11%	3.46%	2.14%	6.69%
EUZ	67 Neutral	€921.09M	19.58	20.78%	1.11%	9.64%	35.18%
COP	60 Neutral	€1.43B	49.55	4.19%	0.20%	1.16%	-43.53%
SHL	57 Neutral	€42.27B	27.87	11.65%	2.13%	4.53%	10.12%
Sector *	55 Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
SBS	49 Neutral	€211.03M	58.01	6.55%	2.71%	-1.64%	22.60%